Rheumatic diseases have a substantial impact on the patient but also on the work status and on a social-economical context. In Europe 25% of the cost of disease is related with rheumatic diseases. We are focusing more on disease activity as a clinical challenge but we have to consider that patient occupational activity is a main issue as a strategic gold… (More)
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.